Vaccinium meridionale Swartz (Agraz): A systematic review of phytochemical composition, extraction technologies, and biological effects.

TL;DR

Agraz (Vaccinium meridionale), a wild Andean berry, contains a dense polyphenol profile dominated by anthocyanins and procyanidins, but evidence for biological effects remains largely confined to laboratory and animal studies, with minimal human clinical data.

What the Study Found

Researchers conducted a systematic review of 43 studies published between 2009 and 2026 examining agraz's chemical composition, extraction methods, and reported biological activities. The analysis reveals a fruit with a notably concentrated phytochemical profile, though the evidence base remains fragmented and heavily skewed toward preclinical research.

Agraz contains a rich mixture of polyphenols, with cyanidin-3-O-galactoside emerging as the dominant anthocyanin. The fruit also supplies hydroxycinnamic acids, flavonols, A- and B-type procyanidins, vitamin C, and oligosaccharides with potential prebiotic properties. One noteworthy finding: pomace, the by-product left after juice or pulp extraction, concentrated flavonol content and contained 3.2-fold higher anthocyanin levels than fresh fruit. This suggests economic value in capturing what would otherwise be waste, though processing stability and bioavailability remain open questions.

On extraction methods, the evidence shows clear technical differentiation. Microwave-assisted extraction was the only method subjected to systematic optimization in the reviewed studies and consistently outperformed conventional approaches under tested conditions. However, ultrasound-assisted extraction was the most frequently employed technique across studies, possibly due to equipment accessibility rather than superior performance data. This gap between what works best in controlled tests and what researchers actually use suggests commercial applications may not yet reflect the evidence hierarchy.

The reported biological activities span antioxidant, anti-inflammatory, anticancer-related, cardiometabolic, and antimicrobial domains. However, the review explicitly flags a critical limitation: most evidence derives from in vitro (cell culture) and preclinical (animal) studies. Clinical human data is limited and methodologically heterogeneous, meaning claims about human benefit rest on a narrow and inconsistent foundation. This pattern is common in ethnobotanical research, where traditional use motivates laboratory investigation but human efficacy remains largely unstudied.

What This Means for You

Agraz represents a case study in the gap between laboratory promise and human evidence. Its phytochemical density, particularly in anthocyanins and procyanidins, mirrors compounds found in other well-studied berries. Yet the absence of rigorous clinical trials means translating lab findings to personal health outcomes carries substantial uncertainty.

If you're considering agraz-based products, the evidence supports treating them as a concentrated polyphenol source with antioxidant potential, consistent with other berry supplements. The pomace concentrate merit attention if available, given its higher anthocyanin density, but extraction method and storage stability will influence final bioactivity. Expect to encounter extraction method variations across products; microwave-assisted options may offer better optimization, though this data point alone is insufficient to guide purchasing.

The prebiotic oligosaccharide content deserves consideration if digestive health is your primary interest, though this too lacks substantial human validation. As with most supplemental polyphenols, benefits would likely depend on consistent intake as part of a pattern that already includes adequate fiber and diverse plant foods rather than as a standalone solution.

Study Details

Sources

Vaccinium meridionale Swartz (Agraz): A systematic review of phytochemical composition, extraction technologies, and biological effects. Food Research International. 2026. PubMed.